ForSight Robotics raises $10M for robotic eye surgery

ForSight has raised $10M for robotic eye surgery.
Image: ForSight Robotics

The fields of tech and medicine continue to grow closer together as more companies find new ways to make an impact. One of the hottest trends in health tech is robotic surgery. Whether it’s a robot that’s designed to operate autonomously or one that gives human surgeons more dexterity, there’s no shortage of demand for robots in the operating room.

ForSight Robotics, a startup from Israel, is specifically focused on robotic eye surgery. It recently raised $10 million in new funding, TechCrunch reports. The company has plenty of expertise behind it and its innovative solution could revolutionize the world of ophthalmic surgery.

A Closer Look

As you might imagine, performing surgery on the human eye is a delicate procedure. Only the most trained surgeons dive into the world of ophthalmology. That means there is a massive disparity between the number of people who need eye surgery and the number of surgeons around to perform those procedures.

According to the British Journal of Ophthalmology, there are only 72 eye surgeons per one million people in developed nations. In undeveloped countries, that figure plummets to just 3.7 surgeons per one million people.

With that in mind, anything that can increase the impact of available surgeons is a useful tool. ForSight’s platform does just that. The startup has built a platform that consists of several types of technology. Robotics, advanced visualization, and machine learning all come together to make surgical procedures more uniform.

In turn, this makes it possible for human surgeons to provide consistent, high-quality care to more patients.

In an interview with TechCrunch, ForSight CEO Daniel Glozman said, “It’s a proprietary technology that we developed… this will allow physicians to democratize surgeries. All physicians around the world will be able to perfect this procedure and perform ophthalmic procedures in a more uniform way.”

The company’s latest funding round was led by Eclipse Ventures and Mithril Capital. It’s worth noting that the firms bring industry expertise along with the new funding. ForSight’s clinical advisory board also includes several ophthalmic surgeons.

Eye Demand

Thanks to innovative new uses for technology, people are finding more ways to take care of their bodies than ever before. Research and products aimed at protecting eye health have been increasingly popular over the past few years.

For instance, earlier this year at CES 2021, EyeQue debuted a system called VisionCheck 2. The platform makes it easy for people to get a prescription for glasses at home using their smartphone. It utilizes artificial intelligence (AI) and computer vision to take measurements and generate appropriate prescriptions.

Meanwhile, companies like DIFF are making it easier for consumers to get their hands on affordable prescription glasses. The glasses can even be fitted with blue-light filtering lenses, a must-have upgrade in today’s world of remote work and constant screen time.

Other applications being explored include bionic eyes that could help restore vision to people who are blind. Late last year, researchers from Monash University earned approval to start the world’s first human trial of a bionic eye.

Ultimately, eye health is only one segment of the much larger health tech space. As a whole, expect this area to continue growing significantly in the coming years. Healthcare and technology have quickly become synonymous and will only become more intertwined as time goes on.


Please enter your comment!
Please enter your name here